NDC 72865-167

Abacavir

Abacavir

Abacavir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xlcare Pharmaceuticals Inc.. The primary component is Abacavir Sulfate.

Product ID72865-167_c334dd5d-ce79-2409-e053-2995a90a48fb
NDC72865-167
Product TypeHuman Prescription Drug
Proprietary NameAbacavir
Generic NameAbacavir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-05-28
Marketing CategoryANDA /
Application NumberANDA091560
Labeler NameXLCare Pharmaceuticals Inc.
Substance NameABACAVIR SULFATE
Active Ingredient Strength300 mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72865-167-60

60 TABLET in 1 BOTTLE (72865-167-60)
Marketing Start Date2021-05-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Abacavir" or generic name "Abacavir"

NDCBrand NameGeneric Name
0121-0897AbacavirAbacavir
0904-6874AbacavirAbacavir
31722-557AbacavirAbacavir
31722-562AbacavirAbacavir
50268-049AbacavirAbacavir
64380-717AbacavirAbacavir
64980-405AbacavirAbacavir Sulfate
65862-073AbacavirAbacavir
65862-089AbacavirAbacavir Sulfate
68084-021AbacavirAbacavir Sulfate
69097-514AbacavirAbacavir
70518-0559AbacavirAbacavir
70518-1274AbacavirAbacavir
72865-167AbacavirAbacavir

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.